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Edited by Felix WielandAbstract The role of haem iron (II) and oxidative stress in the
activation and antimalarial activity of artemisinin is unclear.
Thus, we submitted malaria parasite to modiﬁed culture condi-
tions: artemisinin activity increased by 20–30% under an
oxygen-rich atmosphere (20% O2 instead of ‘‘standard’’ 1%
O2), and by 40–50% in the presence of carboxy-haemoglobin,
and 2% carbon monoxide, conditions which inhibit haem iron (II)
reactivity. In all cases, parasite growth and chloroquine activity
were unaﬀected. We conclude that in the malaria parasite
artemisinin is not activated by haem iron and that free radicals
are not needed for its toxicity.
 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: Malaria; Artemisinin; Chloroquine;
Carbon monoxide; Oxidative stress; P. falciparum1. Introduction
Some thirty years after the discovery of artemisinin, the
active principle of the Chinese herb Artemisia annua, arte-
misinin-type compounds are the most widely used and best
studied antimalarials [1,2]. They act more rapidly than any
other drug and resistance has not been reported yet [2]. Whilst
their activity depends on the presence of the unique 1,2,4-tri-
oxane pharmacophore, it is widely believed that various re-
active intermediates generated after cleavage of the peroxidic
bond within the trioxane, rather than the intact molecule, are
the actual parasiticidal species [3,4]. However, it is not clear
what this presumed ‘activation’ consists of, or if activation is
required at all prior to binding to the active site, especially
after the recent report of a possible target [5].
The activation of artemisinin-type molecules is believed to
be due to the reductive scission of the trioxane pharmacophore
by a one-electron transfer reaction [6,7]. The electron-donor
species, however, is supposed to be iron (II) haem or iron (II)
non-haem, while the prevalent form of iron in the parasite is* Corresponding authors. Fax: +39-2-5031-5068 (D. Taramelli), +39-2-
5031-4072 (D. Monti).
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doi:10.1016/j.febslet.2004.08.039iron (III) haem, stored as insoluble haemozoin [8]. It has been
shown in chemical experiments that iron (II) haem ‘‘activates’’
artemisinin to generate a variety of products, the majority of
which appear to be inert [9]. The lethal eﬀects on the parasite
have been ascribed either to the formation of C-centred radi-
cals that alkylate target molecules or to the generation of
oxygen radicals that could damage membranes [3,4,10].
There is an apparent conﬂict in these hypotheses. The elec-
tron transfer, i.e., the reductive scission of artemisinin, would
be favoured in a low-oxidant, reducing environment, whereas
the toxic eﬀects of artemisinin-derived free radicals would be
ampliﬁed in an oxygen-rich environment; in other words, the
carbon-centred free radicals would react with oxygen to pro-
duce peroxy radicals, which in turn will enhance oxidative
stress.
To clarify this aspect, we set up a ‘‘live’’ test tube in which
P. falciparum parasites were grown in either reducing or oxi-
dizing atmospheres. P. falciparum is microaerophylic and
normally grows under atmosphere containing 1% O2 [11]. The
pro-oxidant environment was obtained by culturing parasites
at 20% O2. For the reducing environment, we eliminated the
O2 carried by haemoglobin by using carbon monoxide (CO)
that forms a stable complex with iron (II) haem [12]; 2% CO
was also added to the ﬁnal atmosphere. This model presents
two main advantages: it allows a study of the activity of ar-
temisinin in a low oxygen, highly reducing environment, with
less opportunity for intercession of peroxidative reactions and
provides an environment in which iron (II) haem is not
available for the reductive activation of the trioxane pharma-
cophore. Parasite growth was monitored and drug sensitivity
assays were carried out with several artemisinin derivatives
and the results compared to that of chloroquine.2. Materials and methods
2.1. Parasite cultures, reagents and drug susceptibility assays
Chloroquine-sensitive (D10) and chloroquine-resistant (CDC/Indo-
cina III, W2) P. falciparum parasites were maintained at 5% haemat-
ocrit (human Aþ RBC) in RPMI 1640 medium (Gibco BRL)
supplemented with 10% heat-inactivated Aþ human plasma, at 37 C
under standard conditions [11]. Chloroquine and artemisinin were
from Sigma, Milan, Italy. Dihydroartemisinin and artesunate were
kindly provided by WHO/TDR, Geneva, CH.blished by Elsevier B.V. All rights reserved.
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water or ethanol (<1% ﬁnal concentration), diluted with medium and
serial twofold dilutions made in microplates (Costar Italia, Milan).
Asynchronous cultures with parasitemia of 1–1.5% and 1% ﬁnal hae-
matocrit were incubated for 72 h at 37 C in three diﬀerent atmo-
spheres: (1 ¼ reducing conditions) 2% CO, 5% CO2, and 93% N2;
(2 ¼ microaerophylic conditions) 1% O2, 5% CO2, and 94% N2;
(3 ¼ pro-oxidant conditions) 20% O2, 5% CO2, and 75% N2. Parasite
growth was determined spectrophotometrically (OD650) by measuring
the activity of the parasite lactate dehydrogenase (pLDH), in control
and drug-treated cultures [13]. Giemsa-stained cultures were also
observed microscopically and under polarized light.
2.2. Statistical analysis
All tests were performed at least ﬁve times in triplicate and results
were analysed by the Student’s paired t test.Fig. 1. Growth rate of P. falciparum parasites, D10 (CQ-S) and W2
(CQ-R) strains, cultured under atmosphere (1), 2% CO (full bars);
atmosphere (2), 1% O2 (striped bars); atmosphere (3) 20% O2 (empty
bars). Parasite growth was checked after 72 h of culture using the
pLDH method. Data are means SD of 15 diﬀerent experiments.
Fig. 2. Wright–Giemsa stained slides of P. falciparum parasites cul-
tured under 1% O2 and oxy-haemoglobin (panels A and C) or 2% CO
and carboxy haemoglobin (panels B and D). (A, B) Normal light; (C,
D) polarized light to visualize birefringent pigment.3. Results
Diﬀerent experimental conditions were set up to evaluate the
role of iron (II)-haem and oxygen tension on the growth and
the sensitivity of P. falciparum to artemisinin derivatives. By
ﬂushing RBC with carbon monoxide (CO), we obtained a
stable complexation of iron (II)-haem with CO. This was
conﬁrmed by UV–VIS spectrophotometry, which showed the
shift in absorption from 414 nm of oxy-haemoglobin to 420
nm of carboxy-haemoglobin. In addition, 2% CO, and no
oxygen, was part of the gas mixture used for the growth of
parasites and the drug assays. The ﬁnal atmospheres of the
cultures contained: (1) 2% CO (reducing environment); (2) 1%
O2 (‘‘standard’’ microaerophylic environment); and (3) 20%
O2 (oxidant environment).
The viability of parasite cultures and the rate of growth did
not change, nor did the production of birefringent pigment
inside the parasite food vacuoles, under any of these culture
conditions (Figs. 1 and 2). In particular, parasites could be
cultured and were viable for more than a month under 2% CO,
atmosphere (1); their spectrum of drug sensitivities did not
change; and they grew normally when cultured again under
oxygenated conditions [12].
The response to artemisinin and chloroquine diﬀered when
experimental conditions were changed. In the reducing 2% CO,
atmosphere (1), the activity of artemisinin was signiﬁcantly
higher (IC50 lower) than in the microaerophylic atmosphere (2)
of 1% O2 (P < 0:05), while, like in previous experiments [12],
the activity of chloroquine was unaltered (Fig. 3). On average,
the activity of artemisinin was 1.86-fold increased for the D10
strain and 2.53-fold increased for the W2 strain after 72 h. For
the artemisinin derivatives, artesunate and dihydroartemisinin,
the IC50 values decreased signiﬁcantly (increased activity) in
atmosphere (1) (Table 1, column 1) vs. atmosphere (2) (column
2).
The antimalarial activity of artemisinin increased (IC50 was
lower) also in the oxidant atmosphere (3) (20% O2) compared
to the microaerophylic atmosphere (2) (1% O2) (Table 1,
column 3). On average, activity increased by 1.56-fold and
1.43-fold for the D10 and W2 strain, respectively, at 20% O2
compared to 1% O2. Similar results were obtained with ar-
tesunate or dihydroartemisinin. For artesunate activity in-
creased by 1.84-fold and 2.49-fold and for dihydroartemisinin
by 1.53-fold and 2.00-fold for D10 and W2, respectively.
The relative potency of the three drugs, dihydroartemisinin
> artesunate > artemisinin was maintained under diﬀerent
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Fig. 3. Antimalarial activity of artemisinin (ARM) and chloroquine
(CQ) against P. falciparum strain D10. The assay was done for 72 h
under atmosphere (1), 2% CO or atmosphere (2), 1% O2. Parasite
growth was evaluated using the pLDH method. The data are the re-
sults of a representative experiment in triplicate, out of six conducted
under the same conditions. Artemisinin in atmosphere 1 vs. atmo-
sphere 2, P < 0:05; Chloroquine in atmosphere 1 vs. atmosphere 2, not
signiﬁcant.
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O2 > 1% O2 (Table 1).4. Discussion
The ‘activation’ theory for artemisinin antimalarials is lar-
gely based upon data obtained from experiments using
chemical reagents in conditions which may not reﬂect the
complexity of the living parasites. In the present paper, we
addressed the question using whole parasite cultures and
adapting simple methodologies to evaluate the putative roles
of iron (II) haem and oxygen in determining drug action. We
reasoned that working on the whole parasite, as opposed to
mere chemical or biochemical assays, would oﬀer new bio-
logical insights for further, more advanced, investigations.
Two questions were addressed: (1) Is iron (II) haem needed
for the activation of artemisinin type antimalarials? (2) Do the
artemisinins kill the parasite via enhanced oxidative stress?
Our data strongly indicate that haem iron (II) is not essential
and that oxidative stress is likely to play a marginal role in the
mechanism of action of artemisinins, as we already reportedTable 1
Antimalarial activity of artemisinin derivatives against D10 (CQ-S) and W2
Drugs 2% CO
atmosphere 1
D10 IC50 (ng/ml) Artemisinin 4.44 2.67a
Artesunate 1.05 0.69a
Dihydroartemisinin 0.56 0.40b
W2 IC50 (ng/ml) Artemisinin 1.39 0.82a
Artesunate 0.58 0.22b
Dihydroartemisinin 0.22 0.07a
Data are means SD of ﬁve diﬀerent experiments in triplicate.
aAtmosphere 1 vs. atmosphere 2, P < 0:01.
bAtmosphere 1 vs. atmosphere 2, P < 0:05.
cAtmosphere 3 vs. atmosphere 2, P < 0:05.
dAtmosphere 3 vs. atmosphere 2, P < 0:01.for chloroquine [12]. The experimental model adopted was
appropriate for the studies: parasite viability was unaﬀected by
carbon monoxide or diﬀerent oxygen tensions and the relative
potencies of artemisinin compounds remained the same.
In the presence of CO-haemoglobin and 2% CO in the at-
mosphere, the activity of artemisinin and its derivatives
increased signiﬁcantly in both chloroquine-sensitive and -re-
sistant strains, while no change was observed for chloroquine
[12].
This is the ﬁrst demonstration in parasites that iron (II)
haem is not necessary for the antimalarial activity of arte-
misinin, since in the presence of CO, iron (II) is no longer
available for the reductive scission of the trioxane pharmaco-
phore. These data in parasites are in good agreement with the
observation that the chemical reactivity of artemisinins with
iron (II) haem does not correlate with their biological activity
[14]. In a previous paper, we also showed that artemisinin and
derivatives do not inhibit beta haematin formation, thus pro-
viding evidence against these molecules binding to iron (III)
haem [15].
If haem iron is not the main activator of artemisinins, we
have to postulate the existence, in the parasite, of an alter-
native one-electron transfer reaction, which is CO-insensitive
and which can activate these molecules. It may be located ei-
ther in the parasite cytoplasm or in the food vacuole, as sug-
gested by the sub-cellular distribution of artemisinins in
infected RBC [5,16]. Alternatively, activation may not be re-
quired at all for the parasiticidal activity. Due to the propen-
sity of the molecule to accept one electron, artemisinin could
act as a competitive inhibitor of an electron transfer system
crucial for the parasite. Artemisinin would be intrinsically
active, independently of generation of scission products.
More intriguing are the results of the eﬀect of oxy-haemo-
globin and oxygen tension on artemisinin activity. When oxy-
haemoglobin is used, iron (II) haem may be present as a
transient intermediate. It will undergo rapid oxidation by ox-
ygen to iron (III) haematin, which transforms to haemozoin.
The iron (II) haem may also react with artemisinin, forming
artemisinin haem-adducts [3,4,14]. As indicated above, the
radicals leading to the haem adducts may escape from the
haem environment and cause damage via alkylation of yet
undeﬁned biomolecules [3,17], or generate either hydroperox-
ides or oxygen radicals toxic for the parasites [4].
We infer from our results that the increased activity seen in
2% CO may be due to the fact that the cleavage of artemisinin
by iron (II) haem is a competitive process, which actually leads(CQ-R) strains of P. falciparum cultured under diﬀerent atmospheres
1% O2
atmosphere 2
20% O2
atmosphere 3
8.27 2.41 5.27 3.22c
2.37 1.56 1.29 0.41c
1.04 0.69 0.68 2.26c
3.51 1.41 2.47 1.19c
1.32 0.56 0.53 0.05c
0.52 0.23 0.26 0.06d
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to antimalarial activity [9]. That is to say that, in the standard
microaerophylic culture conditions, a competitive degradation
of the drug occurs, which leaves only a relatively small pro-
portion of it available to exert its antimalarial eﬀect. There are
biological observations in support of this hypothesis: unlike
other antimalarials, artemisinins are eﬀective against the ring
stage of intraerythrocytic parasites, during which very little
haemoglobin is ingested and little, if any, iron (II) haem is
available. Interestingly, Skinner et al. [18] unlike others [19]
reported that the relative potency of artemisinin on later
trophozoites is lower. The increasing levels of iron (II) haem
during trophozoite growth may be the reasons for that.
The scene changes again when the oxygen pressure is in-
creased to 20%. Under this atmosphere, we observed a 20–30%
improvement in artemisinin activity over 1% oxygen. This was
not unexpected, since previous data showed that 17% O2 in the
atmosphere induced a 29% increase of artemisinin activity [10].
These results may be attributed to the generation of increased
oxidative stress [4].
However, we favour an alternative hypothesis which we
consider more consistent with our overall results: under 20%
oxygen, iron (II) haem is preferentially and more rapidly oxi-
dized to iron (III) haem than in 1% oxygen. Thus, less iron (II)
haem reacts with artemisinin andmore (bioactive) artemisinin is
available to exert its parasitocidal activity. Yet a certain level of
cleavage must still take place at 20% oxygen, because artemis-
inin in this case is on an average 10% less active than under CO.
We should mention here that it is indeed possible that ar-
temisinin acts via a diﬀerent mechanism to oxidative stress. A
new target, the Ca2þ-dependent Plasmodium falciparum AT-
Pase (PfATP6), an enzyme located in the membrane of the
parasite endoplasmic reticulum, was recently reported [5]. Al-
though it was stated in that work that iron was required for
activation, our data indicate that iron (II) haem may not be
required at all.
What is the real situation in vivo? We would like to point out
that, while the conditions used for the CO model have clearly
no bearing with the reality of parasite infection in humans,
they serve to establish an interesting experimental system to
assess the role of iron (II) haem and oxidative stress in arte-
misinin activity. Also, this model conﬁrms that P. falciparum is
strongly microaerophylic, probably even anaerobic in certain
stages of its life cycle. In a microaerophylic environment, the
hypothesis that oxygen radicals and oxidative stress are in-
volved in artemisinin activity, as outlined above, should be
reconsidered. This leaves open the question of the existence ofdiﬀerent, yet to be identiﬁed target(s) for these drugs as indeed
suggested by the signiﬁcant antitumour activity demonstrated
for several artemisinin derivatives [8,20].
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